Literature DB >> 15542594

Crystal structures of novel vascular endothelial growth factors (VEGF) from snake venoms: insight into selective VEGF binding to kinase insert domain-containing receptor but not to fms-like tyrosine kinase-1.

Kyoko Suto1, Yasuo Yamazaki, Takashi Morita, Hiroshi Mizuno.   

Abstract

Vascular endothelial growth factor-A (VEGF-A(165)) exerts multiple effects upon binding to the fms-like tyrosine kinase-1 (Flt-1) and the kinase insert domain-containing receptor (KDR). We recently identified two novel snake venom VEGFs (vammin and VR-1) having unique properties. These VEGFs, designated VEGF-Fs, are highly specific ligands for the kinase insert domain-containing receptor and exhibit potent biological activity both in vitro and in vivo when compared with VEGF-A(165). Here, we solved the crystal structures of vammin and VR-1 at 1.9 and 2.0 A resolutions, respectively. Both structures are very similar to each other, and these structures exhibit similar but significantly different features from the known structures of other VEGFs. These differences include a conformational difference in receptor-binding loop 3 caused by an amino acid residue insertion and a difference in surface potential on the possible binding surface for domain 3 of the receptor. These structural differences may be related to the highly selective ligand properties of VEGF-F.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542594     DOI: 10.1074/jbc.M411395200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Biomarkers of lymphatic function and disease: state of the art and future directions.

Authors:  Kenta Nakamura; Stanley G Rockson
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

2.  The pharmacology study of a new recombinant human VEGF receptor-fc fusion protein on experimental choroidal neovascularization.

Authors:  Ming Zhang; Dechao Yu; Chun Yang; Qingjie Xia; Wang Li; Bin Liu; Hong Li
Journal:  Pharm Res       Date:  2008-10-15       Impact factor: 4.200

3.  Coralsnake Venomics: Analyses of Venom Gland Transcriptomes and Proteomes of Six Brazilian Taxa.

Authors:  Steven D Aird; Nelson Jorge da Silva; Lijun Qiu; Alejandro Villar-Briones; Vera Aparecida Saddi; Mariana Pires de Campos Telles; Miguel L Grau; Alexander S Mikheyev
Journal:  Toxins (Basel)       Date:  2017-06-08       Impact factor: 4.546

4.  Anti-angiogenic effect of KH902 on retinal neovascularization.

Authors:  Fei Wang; Yujing Bai; Wenzhen Yu; Na Han; Lvzhen Huang; Min Zhao; Aiyi Zhou; Mingwei Zhao; Xiaoxin Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-06-06       Impact factor: 3.117

5.  Snake venom Vascular Endothelial Growth Factors (VEGF-Fs) exclusively vary their structures and functions among species.

Authors:  Yasuo Yamazaki; Yukiko Matsunaga; Yuko Tokunaga; Shinya Obayashi; Mai Saito; Takashi Morita
Journal:  J Biol Chem       Date:  2009-02-10       Impact factor: 5.157

6.  Novel vascular endothelial growth factor D variants with increased biological activity.

Authors:  Pyry I Toivanen; Tiina Nieminen; Lenita Viitanen; Annamari Alitalo; Miia Roschier; Suvi Jauhiainen; Johanna E Markkanen; Olli H Laitinen; Tomi T Airenne; Tiina A Salminen; Mark S Johnson; Kari J Airenne; Seppo Ylä-Herttuala
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

Review 7.  Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis.

Authors:  Erhard Hofer; Bernhard Schweighofer
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

Review 8.  Molecular and functional diversity of vascular endothelial growth factors.

Authors:  Yasuo Yamazaki; Takashi Morita
Journal:  Mol Divers       Date:  2006-11       Impact factor: 3.364

Review 9.  Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines.

Authors:  Shalini Iyer; K Ravi Acharya
Journal:  FEBS J       Date:  2011-10-07       Impact factor: 5.542

10.  Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys.

Authors:  Ming Zhang; Junjun Zhang; Mi Yan; Hong Li; Chun Yang; Dechao Yu
Journal:  Mol Vis       Date:  2008-01-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.